FDA NDA · NDA011045

MILPREM-200

Sponsor: MEDPOINTE PHARM HLC

APPLICATION

NDA011045

TYPE

NDA

ROUTE

ORAL

DOSAGE FORM

TABLET

MARKETING STATUS

Discontinued

Products

MILPREM-200Discontinued

ESTROGENS, CONJUGATED 0.45MG, MEPROBAMATE 200MG · TABLET · ORAL

MILPREM-400Discontinued

ESTROGENS, CONJUGATED 0.45MG, MEPROBAMATE 400MG · TABLET · ORAL

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.